TSKS
Testis-specific serine kinase substrate
Also known as: PPP1R161, TSKS_HUMAN, TSSKS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJT2
- Gene
- TSKS
- Ensembl
- ENSG00000126467
- Chromosome
- 19
- Canonical length
- 592 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene may play a role in testicular physiology, spermatogenesis or spermiogenesis. Expression of the encoded protein is highest in the testis and down-regulated in testicular cancer. The gene is localized to the region 19q13.3 among the related RAS viral oncogene homolog (RRAS) and interferon regulatory factor 3 (IRF3) genes, which are both involved in tumorigenesis pathways and progression. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
592 residues, UniProt reviewed canonical sequence.
>Q9UJT2|TSKS
1 MASVVVKTIW QSKEIHEAGD TPTGVESCSQ LVPEAPRRVT SRAKGIPKKK KAVSFHGVEP
61 QMSHQPMHWC LNLKRSSACT NVSLLNLAAM EPTDSTGTDS TVEDLSGQLT LAGPPASPTL
121 PWDPDDADIT EILSGVNSGL VRAKDSITSL KEKTNRVNQH VQSLQSECSV LSENLERRRQ
181 EAEELEGYCI QLKENCWKVT RSVEDAEIKT NVLKQNSALL EEKLRYLQQQ LQDETPRRQE
241 AELQEPEEKQ EPEEKQEPEE KQKPEAGLSW NSLGPAATSQ GCPGPPGSPD KPSRPHGLVP
301 AGWGMGPRAG EGPYVSEQEL QKLFTGIEEL RREVSSLTAR WHQEEGAVQE ALRLLGGLGG
361 RVDGFLGQWE RAQREQAQTA RDLQELRGRA DELCTMVERS AVSVASLRSE LEGLGPLKPI
421 LEEFGRQFQN SRRGPDLSMN LDRSHQGNCA RCASQGSQLS TESLQQLLDR ALTSLVDEVK
481 QRGLTPACPS CQRLHKKILE LERQALAKHV RAEALSSTLR LAQDEALRAK NLLLTDKMKP
541 EEKMATLDHL HLKMCSLHDH LSNLPLEGST GTMGGGSSAG TPPKQGGSAP EQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSKS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 116 nTPM
Expression across tissuesHPA
Tissue
- testis: 116 nTPM
- skin: 1.7 nTPM
- heart muscle: 1.5 nTPM
- adipose tissue: 1.1 nTPM
- blood vessel: 0.9 nTPM
- breast: 0.9 nTPM
Single-cell type
- late spermatids: 1,393 nCPM
- early spermatids: 1,128 nCPM
- late primary spermatocytes: 295 nCPM
- migrating cytotrophoblasts: 30 nCPM
- thymic myoid cells: 18 nCPM
- fibro-adipogenic progenitors: 17 nCPM
Immune cell
- non-classical monocyte: 1 nTPM
- memory CD4 T-cell: 0.8 nTPM
- myeloid DC: 0.8 nTPM
- plasmacytoid DC: 0.7 nTPM
- T-reg: 0.7 nTPM
- classical monocyte: 0.5 nTPM
Brain region
- cerebellum: 1.6 nTPM
- white matter: 0.5 nTPM
- basal ganglia: 0.4 nTPM
- cerebral cortex: 0.4 nTPM
- hypothalamus: 0.4 nTPM
- thalamus: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.28
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Testis-specific serine kinase substrate
- Testis-specific serine kinase substrate
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSKS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSKS as an antibody target. Whether an autoantibody or antibody against TSKS could matter depends on whether native TSKS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSKS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSKS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...